RICHMOND, Va. / Apr 09, 2025 / Business Wire / Owens & Minor, Inc. (NYSE: OMI) today announced important milestones in advancing the medical distribution capabilities of its Products & Healthcare Services (P&HS) business segment, which provides essential products and services to thousands of healthcare customers. These milestones are the result of recent company investments in new technology, automation and analytics capabilities geared specifically toward driving greater efficiencies for the P&HS segment and improving the customer experience. Initial roll out will focus on two new Owens & Minor distribution centers in West Virginia and South Dakota.
“Over the past two years, our P&HS teammates have worked creatively and diligently to identify areas where technology investments, operational upgrades and new approaches to how we do business could have a meaningful impact for our customers,” said Andy Long, EVP and CEO, Products & Healthcare Services, Owens & Minor. “We’re excited for these advancements to go live in West Virginia and South Dakota and look forward to the benefits they will provide for other Owens & Minor customers in years to come.”
These new capabilities will be operational at two new Owens & Minor sites starting in 2025:
About Owens & Minor
Owens & Minor, Inc. (NYSE: OMI) is a Fortune 500 global healthcare solutions company providing essential products and services that support care from the hospital to the home.
For over 100 years, Owens & Minor and its affiliated brands, Apria®, Byram®, and HALYARD*, have helped to make each day better for the patients, providers, and communities we serve. Powered by more than 20,000 teammates worldwide, Owens & Minor delivers comfort and confidence behind the scenes so healthcare stays at the forefront. Owens & Minor exists because every day, everywhere, Life Takes Care™.
For more information about Owens & Minor and our affiliated brands, visit owens-minor.com or follow us on LinkedIn and Instagram.
Last Trade: | US$5.34 |
Daily Change: | -0.13 -2.38 |
Daily Volume: | 1,202,087 |
Market Cap: | US$412.460M |
August 11, 2025 February 28, 2025 February 11, 2025 February 03, 2025 |
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MOREClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREEnd of content
No more pages to load